Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Transforming Vaccine Development

Version 1 : Received: 7 June 2020 / Approved: 7 June 2020 / Online: 7 June 2020 (10:11:02 CEST)

How to cite: Black, S.; Bloom, D.E.; Kaslow, D.C.; Pecetta, S.; Rappuoli, R. Transforming Vaccine Development. Preprints 2020, 2020060078 (doi: 10.20944/preprints202006.0078.v1). Black, S.; Bloom, D.E.; Kaslow, D.C.; Pecetta, S.; Rappuoli, R. Transforming Vaccine Development. Preprints 2020, 2020060078 (doi: 10.20944/preprints202006.0078.v1).

Abstract

The urgency to develop vaccines against Covid-19 is putting pressure on the long and expensive development timelines which are normally required for development of lifesaving vaccines. There is a unique opportunity to take advantage of new technologies, smart and flexible design of clinical trials, and evolving regulatory science to speed up vaccine development against Covid-19 and transform vaccine development altogether.

Subject Areas

COVID-19; vaccine; vaccine development; vaccine discovery; systems biology; machine learning; platform technologies; adjuvants; smart clinical trials; human genetics; regulatory convergence; real world evidence; vaccines safety

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.